Cargando…
LHX6 acts as a novel potential tumour suppressor with epigenetic inactivation in lung cancer
LIM homeobox domain 6 (LHX6) is a putative transcriptional regulator that controls the differentiation and development of neural and lymphoid cells. However, the function of LHX6 in cancer development remains largely unclear. Recently, we found that LHX6 is hypermethylated in lung cancer. In this st...
Autores principales: | Liu, W-b, Jiang, X, Han, F, Li, Y-h, Chen, H-q, Liu, Y, Cao, J, Liu, J-y |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3824675/ https://www.ncbi.nlm.nih.gov/pubmed/24157876 http://dx.doi.org/10.1038/cddis.2013.366 |
Ejemplares similares
-
ZAR1 is a novel epigenetically inactivated tumour suppressor in lung cancer
por: Richter, Antje M., et al.
Publicado: (2017) -
TMEM196 acts as a novel functional tumour suppressor inactivated by DNA methylation and is a potential prognostic biomarker in lung cancer
por: Liu, Wen-bin, et al.
Publicado: (2015) -
SMG1 Acts as a Novel Potential Tumor Suppressor with Epigenetic Inactivation in Acute Myeloid Leukemia
por: Du, Yahui, et al.
Publicado: (2014) -
The novel RASSF6 and RASSF10 candidate tumour suppressor genes are frequently epigenetically inactivated in childhood leukaemias
por: Hesson, Luke B, et al.
Publicado: (2009) -
Epigenetic inactivation of tumour suppressor coding and non-coding genes in human cancer: an update
por: Llinàs-Arias, Pere, et al.
Publicado: (2017)